Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 11 Jul 2022
ICER launches initiative to evaluate and advance health technology assessment methods that support health equity
11 July 2022 - Funding from Commonwealth Fund supports a broad based initiative exploring potential changes in all health technology assessment ...
Posted by Michael Wonder on 11 Jul 2022
ECDC and EMA update recommendations on additional booster doses of mRNA COVID-19 vaccines
11 July 2022 - The European Centre for Disease Prevention and Control and the EMA are recommending that second booster ...
Posted by Michael Wonder on 11 Jul 2022
U.S. California will start making its own insulin to combat high drug prices, governor says
8 July 2022 - California Gov. Gavin Newsom announced Thursday that he approved a budget that allocates $100 million for ...
Posted by Michael Wonder on 11 Jul 2022
Governor Ron de Santis takes additional actions to lower prescription drug prices for Floridians
8 July 2022 - Today, Governor Ron DeSantis issued Executive Order 22-164 to drive transparency in prescription costs for Floridians. This ...
Posted by Michael Wonder on 11 Jul 2022
Anthos Therapeutics announces that abelacimab has received FDA fast track designation for the treatment of thrombosis associated with cancer
11 July 2022 - Abelacimab is a dual-acting fully human monoclonal antibody targeting both factor XI and Factor XIa with high ...
Posted by Michael Wonder on 11 Jul 2022
The (harsh) reality of real-world data external comparators for health technology assessment
8 July 2022 - We read with great interest the recently published article by Patel et al. and commend the authors ...
Posted by Michael Wonder on 11 Jul 2022
Drug Utilisation SubCommittee outcome statement
8 July 2022 - The outcome statement from the June 2022 DUSC meeting is now available. ...
Posted by Michael Wonder on 10 Jul 2022
New drug application for treatment of dry eyes disease submitted to FDA
7 July 2022 - A treatment for dry eye symptoms associated with Meibomian gland dysfunction has been submitted under a ...
Posted by Michael Wonder on 10 Jul 2022
Novavax files in Switzerland for expanded conditional marketing authorisation of Nuvaxovid COVID-19 vaccine for adolescents aged 12 through 17 and as a booster in individuals aged 18 and over
7 July 2022 - Novavax today announced the submission of a request to Swissmedic to expand the conditional marketing authorisation ...
Posted by Michael Wonder on 10 Jul 2022
SIGA Technologies receives approval from UK for tecovirimat
8 July 2022 - Treatment approved for smallpox, monkeypox, cowpox and vaccinia complications. ...
Posted by Michael Wonder on 10 Jul 2022
Novavax Nuvaxovid COVID-19 vaccine conditionally authorised in the European Union for adolescents aged 12 through 17
5 July 2022 - Nuvaxovid COVID-19 vaccine is the first protein-based option for adolescents aged 12 through 17 in Europe. ...
Posted by Michael Wonder on 10 Jul 2022
Prices and clinical benefit of national price negotiated anti-cancer medicines in China
8 July 2022 - High prices of anticancer medicines have increased the economic burden for both patients and health insurance systems. ...
Posted by Michael Wonder on 10 Jul 2022
Human genetics evidence supports two-thirds of the 2021 FDA approved drugs
8 July 2022 - In 2021, 50 drugs were approved by the FDA’s Center for Drug Evaluation and Research, continuing a ...
Posted by Michael Wonder on 10 Jul 2022
Millions of Australians to gain access to COVID treatments
10 July 2022 - Eligibility for potentially lifesaving COVID-19 antiviral treatments will be widened from tomorrow, Monday 11 July. ...
Posted by Michael Wonder on 10 Jul 2022
COVID-19 oral treatment eligibility expanded from 11 July 2022
10 July 2022 - From 11 July 2022, more Australians at higher risk of developing severe COVID-19 will be able to ...